Interventional Oncology Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The market is segmented by Product Type (Ablation Devices, Embolization Devices, Microcatheters, Guidewires, and Others), by Cancer Type (Lung Cancer, Liver Cancer, Kidney Cancer, Prostate Cancer, and others), and Geography.

Market Snapshot

interventional oncology devices market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 8.3 %
interventional oncology market

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The interventional oncology devices market is expected to register a CAGR of 8.3% during the forecast period (2020-2025).

The major factors accounting for the growth of the s market include the increase in the incidence rate of cancer worldwide, high preference for the minimally invasive procedures, augmented fundings from the government in developed countries, and the favorable reimbursement scenario for interventional oncology treatment. According to WHO report, cancer is the second leading cause of death globally with 18.1 million new cases and an estimated 9.6 million deaths in 2018. According to the American Cancer Society, in 2020, 1,806,590 new cancer cases and 606,520 cancer deaths are projected to occur in the United States alone. Therefore, an increase in the incidence rate of cancer around the world drives the growth of interventional oncology devices market during the forecast period. However, the stringent regulations in the usage of medical devices may hamper the growth of the market to some extent.

Scope of the Report

Interventional oncology deals with the treatment of various types of cancers using targeted minimally invasive procedures performed under image guidance. As the minimally invasive procedures are less painful and low risk than other traditional surgeries, interventional oncology is gaining a lot of importance in the treatment of cancer.

By Product Type
Ablation Devices
Microwave ablation
Radiofrequency ablation
Other Product Types
Embolization Device
Other Embolization Devices
By Cancer Type
Lung cancer
Breast Cancer
Liver Cancer
Kidney Cancer
Prostate Cancer
Other Cancer Types
By Geography
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Lung Cancer Dominates the Market Followed by Breast Cancer and the Trend is Expected to be Same During the Forecast Period.

According to the WHO, lung cancer constitutes the major proportion of total cancer cases in the world accounting for 2.09 million cases. As the world population is increasing continuously, the incidence rate of cancer is also expected to grow. This factor is expected to drive the growth of the market during the forecast period.

 interventional oncology companies

North America Dominates the Market and the Same is Expected Over the Forecast Period.

North America is expected to dominate the overall market during the forecast period. The factors, such as advancements in technology and affordability to minimally invasive procedures for the effective management of cancer in the developed countries, are responsible for the growth of the market. According to the National Cancer Institute, the US Department of Health and Human Services, one in 16 people in the United States will be diagnosed with lung cancer in their lifetime. More than 228,000 people in the United State are diagnosed with lung cancer in 2018, with a new diagnosis every 2.3 minutes. this factor leads to the growth of the interventional oncology devices market in North America.

 interventional oncology medical devices company

Competitive Landscape

The Interventional Oncology Devices market is moderately competitive and consists of several major players. With increasing consolidations of various organizations such as BTG acquisition by Boston Scientific in 2019, it is expected to generate competitive rivalry among the key players in the future. Some of the major players of the market are Boston Scientific Corporation, Medtronic plc, Merit Medical Systems Inc., Terumo Corporation, HealthTronics Inc., etc.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Perpetual Increase in the Incidence Rate of Cancers Worldwide

      2. 4.2.2 High Preference for Minimally Invasive Procedures

      3. 4.2.3 Augmented Funding from the Government in the Developed Countries

      4. 4.2.4 Favorable Reimbursement Scenario for Interventional Oncology Treatment

    3. 4.3 Market Restraints

      1. 4.3.1 Financial Burden on the Companies due to Product Recall

      2. 4.3.2 Dearth of Trained Interventional Oncologists and Clinical Evidence for Localized Treatment Region

      3. 4.3.3 Strigent Regulatory Changes

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product Type

      1. 5.1.1 Ablation Devices

        1. Microwave ablation

        2. Radiofrequency ablation

        3. Cryoablation

        4. Other Product Types

      2. 5.1.2 Embolization Device

      3. 5.1.3 Microcatheters

      4. 5.1.4 Guidewires

      5. 5.1.5 Other Embolization Devices

    2. 5.2 By Cancer Type

      1. 5.2.1 Lung cancer

      2. 5.2.2 Breast Cancer

      3. 5.2.3 Liver Cancer

      4. 5.2.4 Kidney Cancer

      5. 5.2.5 Prostate Cancer

      6. 5.2.6 Other Cancer Types

    3. 5.3 By Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Boston Scientific Corporation

      2. 6.1.2 Medtronic PLC

      3. 6.1.3 Terumo Corporation

      4. 6.1.4 Merit Medical Systems Inc.

      5. 6.1.5 CR Bard Inc.

      6. 6.1.6 Profound Medical Corp.

      7. 6.1.7 AngioDynamics Inc.

      8. 6.1.8 Cook Medical LLC

      9. 6.1.9 HealthTronics Inc.

    2. *List Not Exhaustive

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Interventional Oncology Devices Market market is studied from 2018 - 2026.

The Interventional Oncology Devices Market is growing at a CAGR of 8.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Boston Scientific Corporation , Medtronic plc , Terumo Corporation , Merit Medical Systems, Inc are the major companies operating in Interventional Oncology Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!